36.56
price up icon0.01%   0.07
 
loading
前日終値:
$36.63
開ける:
$36.5
24時間の取引高:
103.89K
Relative Volume:
0.03
時価総額:
$15.82B
収益:
$2.31B
当期純損益:
$1.66B
株価収益率:
15.90
EPS:
2.3
ネットキャッシュフロー:
$827.02M
1週間 パフォーマンス:
+1.76%
1か月 パフォーマンス:
+1.09%
6か月 パフォーマンス:
+13.80%
1年 パフォーマンス:
+32.01%
1日の値動き範囲:
Value
$36.50
$36.74
1週間の範囲:
Value
$35.79
$37.13
52週間の値動き範囲:
Value
$24.05
$38.00

Royalty Pharma Plc Stock (RPRX) Company Profile

Name
名前
Royalty Pharma Plc
Name
セクター
Healthcare (1143)
Name
電話
(212) 883-0200
Name
住所
110 EAST 59TH STREET, NEW YORK, NY
Name
職員
99
Name
Twitter
Name
次回の収益日
2025-02-11
Name
最新のSEC提出書
Name
RPRX's Discussions on Twitter

RPRX を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
RPRX
Royalty Pharma Plc
36.59 15.83B 2.31B 1.66B 827.02M 2.30
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
417.68 107.45B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
478.99 64.39B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
574.35 61.13B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
841.11 52.30B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
165.57 35.49B 398.11M -1.03B -868.57M -5.7032

Royalty Pharma Plc Stock (RPRX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-09-30 開始されました Goldman Buy
2025-05-16 開始されました Morgan Stanley Overweight
2024-06-03 ダウングレード UBS Buy → Neutral
2022-06-14 再開されました UBS Buy
2022-05-13 開始されました Scotiabank Sector Outperform
2022-04-27 開始されました Goldman Buy
2022-04-14 アップグレード JP Morgan Neutral → Overweight
2022-04-06 再開されました Morgan Stanley Overweight
2021-10-29 アップグレード Citigroup Neutral → Buy
2021-07-30 開始されました Tigress Financial Buy
2020-11-09 アップグレード UBS Neutral → Buy
2020-07-14 開始されました Evercore ISI In-line
2020-07-13 開始されました BofA Securities Buy
2020-07-13 開始されました Citigroup Neutral
2020-07-13 開始されました Cowen Outperform
2020-07-13 開始されました Goldman Neutral
2020-07-13 開始されました JP Morgan Neutral
2020-07-13 開始されました Morgan Stanley Equal-Weight
2020-07-13 開始されました SunTrust Buy
2020-07-13 開始されました UBS Neutral
すべてを表示

Royalty Pharma Plc (RPRX) 最新ニュース

pulisher
05:04 AM

Royalty Pharma PLC (NASDAQ:RPRX) Short Interest Update - MarketBeat

05:04 AM
pulisher
04:24 AM

Allianz Asset Management GmbH Increases Stock Position in Royalty Pharma PLC $RPRX - MarketBeat

04:24 AM
pulisher
03:22 AM

Why Royalty Pharma plc (RPD) stock could outperform next yearEarnings Growth Summary & Free Expert Approved Momentum Trade Ideas - newser.com

03:22 AM
pulisher
02:01 AM

What the charts say about Royalty Pharma plc todayJuly 2025 Breakouts & Verified Entry Point Signals - newser.com

02:01 AM
pulisher
01:48 AM

Is Royalty Pharma plc (RPD) stock a buy during volatile markets2025 Technical Overview & Free Fast Entry Momentum Trade Alerts - newser.com

01:48 AM
pulisher
12:25 PM

Detecting support and resistance levels for Royalty Pharma plcEarnings Risk Summary & Precise Entry and Exit Recommendations - newser.com

12:25 PM
pulisher
Oct 20, 2025

Is Royalty Pharma plc (RPD) stock undervalued historicallyWeekly Trading Summary & Verified Technical Trade Signals - nchmf.gov.vn

Oct 20, 2025
pulisher
Oct 20, 2025

Is Royalty Pharma plc reversing from oversold territoryMarket Activity Summary & Technical Pattern Based Buy Signals - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

Using Python tools to backtest Royalty Pharma plc strategiesWeekly Profit Analysis & Stock Portfolio Risk Management - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

What candlestick patterns are forming on Royalty Pharma plcWeekly Gains Report & Smart Money Movement Tracker - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

Does Royalty Pharma plc qualify in momentum factor screening2025 Trading Volume Trends & AI Driven Stock Reports - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

What indicators show strength in Royalty Pharma plcQuarterly Earnings Report & Safe Capital Growth Tips - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

Price-Driven Insight from (RPRX) for Rule-Based Strategy - news.stocktradersdaily.com

Oct 20, 2025
pulisher
Oct 19, 2025

Unlocking Q1 Potential of Royalty Pharma (RPRX): Exploring Wall Street Estimates for Key Metrics - sharewise.com

Oct 19, 2025
pulisher
Oct 19, 2025

Nordea Investment Management AB Boosts Position in Royalty Pharma PLC $RPRX - MarketBeat

Oct 19, 2025
pulisher
Oct 18, 2025

Why retail investors pile into Royalty Pharma plc stockMarket Weekly Review & Daily Risk Controlled Trade Plans - newser.com

Oct 18, 2025
pulisher
Oct 18, 2025

Royalty Pharma PLC (NASDAQ:RPRX) to Issue Quarterly Dividend of $0.22 - MarketBeat

Oct 18, 2025
pulisher
Oct 18, 2025

Is Royalty Pharma plc (RPD) stock bottoming after sell offEarnings Risk Summary & Stepwise Swing Trade Plans - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 18, 2025

How strong is Royalty Pharma plc stock revenue growth2025 Key Lessons & Proven Capital Preservation Tips - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 18, 2025

Market Moves: How strong is Royalty Pharma plc stock revenue growthTake Profit & Precise Buy Zone Identification - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 18, 2025

Will Royalty Pharma plc stock benefit from upcoming earnings reports2025 EndofYear Setup & Consistent Return Strategy Ideas - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 17, 2025

Trading Recap: Is Royalty Pharma plc (RPD) stock positioned for secular growth2025 Technical Overview & Fast Exit and Entry Strategy Plans - nchmf.gov.vn

Oct 17, 2025
pulisher
Oct 17, 2025

Why Royalty Pharma plc stock is a must watch in 2025July 2025 Rallies & Stock Market Timing Techniques - nchmf.gov.vn

Oct 17, 2025
pulisher
Oct 17, 2025

Royalty Pharma Keeps Quarterly Dividend at $0.22 a Share, Payable Dec. 10 to Holders of Record on Nov. 14 - MarketScreener

Oct 17, 2025
pulisher
Oct 17, 2025

Royalty Pharma plc Approves Dividend on Class A Ordinary Share for Fourth Quarter of 2025 , Payable on December 10, 2025 - MarketScreener

Oct 17, 2025
pulisher
Oct 17, 2025

Royalty Pharma plc Announces Fourth Quarter 2025 Dividend of $0.22 per Class A Ordinary Share - Quiver Quantitative

Oct 17, 2025
pulisher
Oct 17, 2025

Royalty Pharma Declares Fourth Quarter 2025 Dividend - Bluefield Daily Telegraph

Oct 17, 2025
pulisher
Oct 17, 2025

$0.22 Q4 2025 Dividend: Royalty Pharma Declares Payment Dec 10, Record Date Nov 14, 2025 - Stock Titan

Oct 17, 2025
pulisher
Oct 17, 2025

Aberdeen Group plc Grows Position in Royalty Pharma PLC $RPRX - MarketBeat

Oct 17, 2025
pulisher
Oct 16, 2025

S Bank Fund Management Ltd Buys Shares of 43,508 Royalty Pharma PLC $RPRX - MarketBeat

Oct 16, 2025
pulisher
Oct 16, 2025

Is Royalty Pharma plc RPD a good long term investmentEarnings Per Share Trends & Big Returns, Small Investment – Learn How - earlytimes.in

Oct 16, 2025
pulisher
Oct 15, 2025

What’s the recovery path for long term holders of Royalty Pharma plcMarket Risk Analysis & Safe Capital Growth Trade Ideas - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

Morningstar Investment Management LLC Acquires Shares of 8,307 Royalty Pharma PLC $RPRX - MarketBeat

Oct 15, 2025
pulisher
Oct 14, 2025

Callan Family Office LLC Buys Shares of 16,418 Royalty Pharma PLC $RPRX - MarketBeat

Oct 14, 2025
pulisher
Oct 13, 2025

Royalty Pharma (RPRX) Valuation: Is There More Upside After This Year’s 40% Rally? - Yahoo Finance

Oct 13, 2025
pulisher
Oct 13, 2025

Royalty pharma projects 6-12% growth in 2025 portfolio receipts with $2B share buyback plan - MSN

Oct 13, 2025
pulisher
Oct 13, 2025

3 Healthcare Stocks We Keep Off Our Radar - The Globe and Mail

Oct 13, 2025
pulisher
Oct 13, 2025

Royalty Pharma plc (RPRX) Stock Analysis: Unveiling a 23.59% Upside Potential in the Biotech Royalty Space - DirectorsTalk Interviews

Oct 13, 2025
pulisher
Oct 12, 2025

Is this a good reentry point in Royalty Pharma plcQuarterly Investment Review & AI Forecasted Stock Moves - newser.com

Oct 12, 2025
pulisher
Oct 12, 2025

Royalty Pharma PLC $RPRX Shares Sold by Board of the Pension Protection Fund - MarketBeat

Oct 12, 2025

Royalty Pharma Plc (RPRX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$86.25
price up icon 0.00%
$29.94
price down icon 2.21%
$106.64
price down icon 1.24%
biotechnology ONC
$314.10
price down icon 1.23%
$165.78
price down icon 1.35%
大文字化:     |  ボリューム (24 時間):